Tess V Clendenen

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. ncbi Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
  2. ncbi Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Divison of Epidemiology, New York, NY 10016, USA
    Magn Reson Imaging 31:1-9. 2013
  3. ncbi Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
  4. ncbi Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
  5. ncbi Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
  6. ncbi Circulating vitamin d and risk of epithelial ovarian cancer
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Oncol 2009:672492. 2009
  7. ncbi Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
    Tess V Clendenen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 18:275-81. 2009
  8. ncbi Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Lett 260:209-15. 2008

Detail Information

Publications8

  1. ncbi Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
    ..Indirect evidence from experimental and epidemiological studies suggests that prolactin may be involved in ovarian cancer development. However, the relationship between circulating prolactin levels and risk of ovarian cancer is unknown...
  2. ncbi Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Divison of Epidemiology, New York, NY 10016, USA
    Magn Reson Imaging 31:1-9. 2013
    ..We conducted a pilot study to identify whether MRI parameters are sensitive to hormone-induced changes in the breast during the natural menstrual cycle and whether changes could also be observed during an oral contraceptive (OC) cycle...
  3. ncbi Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
    ..Our findings suggest that risk factors for chronic diseases (age, BMI, menopausal status, parity, NSAID use, family history of breast and ovarian cancer, and smoking) are associated with inflammation markers in healthy women...
  4. ncbi Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
    ..Cytokines are involved in the development of chronic diseases, including cancer. It is important to evaluate the temporal reproducibility of cytokines in plasma prior to conducting epidemiologic studies utilizing these markers...
  5. ncbi Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
    ..The purpose of this study was to assess the association between circulating levels of inflammation mediators and subsequent risk of ovarian cancer...
  6. ncbi Circulating vitamin d and risk of epithelial ovarian cancer
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Oncol 2009:672492. 2009
    ..59-2.01). In addition, there was no evidence of an interaction effect between VDR SNP genotype or haplotype and circulating 25(OH)D levels in relation to ovarian cancer risk, although more complex gene-environment interactions may exist...
  7. ncbi Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
    Tess V Clendenen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 18:275-81. 2009
    ..Our results suggest that endogenous estrone is associated with increased risk of colorectal cancer in postmenopausal women...
  8. ncbi Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Lett 260:209-15. 2008
    ..These observations do not support a role for BSMI, APAI, TAQI, and FOKI polymorphisms in epithelial ovarian cancer in a predominantly Caucasian population...